)
)
Novabay Pharmaceuticals Investor Relations Material
Latest events
Q2 2024
Novabay Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Novabay Pharmaceuticals Inc
Access all reports
NovaBay Pharmaceuticals Inc. is a biopharmaceutical company that focuses on the development and commercialization of innovative products for the eye care market. The company specializes in creating novel, fast-acting, synthetic anti-infectives designed to mimic the body’s natural defense mechanisms against infection. Its product portfolio includes solutions for eye care, such as Avenova, an antimicrobial lid and lash solution, as well as products for wound care and skincare. The company is headquartered in Emeryville, California, and its shares are listed on the NYSE.
Latest articles
)
The Art of Portfolio Management: Lessons from Tom O'Hara
Tom O'Hara shares insights on stock picking, navigating market distractions, and the importance of one-on-one meetings with management teams.
4 Oct 2024
)
The Samsung Co-CEOs: Jong-Hee Han & Young-Hyun Jun
Samsung Electronics' dual-CEO structure, led by Jong-Hee Han and Young-Hyun Jun, is designed to navigate the complexities of its diverse business.
3 Oct 2024
)
Irwin Jacobs & Andrew Viterbi: Qualcomm's Pioneering Founders
In 1985, Irwin Jacobs and Andrew Viterbi co-founded Qualcomm, a leading company in telecommunications and semiconductor innovation.
3 Oct 2024
Ticker symbol
NBY
Country
🇺🇸 United States